Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(14%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_2
1
14%
Ph not_applicable
4
57%
Ph phase_4
1
14%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(6)

Detailed Status

Completed6
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (16.7%)
Phase 41 (16.7%)
N/A4 (66.7%)

Trials by Status

completed686%
recruiting114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DEVICE
Total Trials
7